SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research

被引：1
|
作者：
Guven, Deniz C. [1 ]
Sahin, Taha K. [2 ]
Akin, Serkan [1 ,3 ]
Uckun, Fatih M. [4 ,5 ]
机构：
[1] Hacettepe Univ, Inst Canc, Dept Med Oncol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Internal Med, Ankara, Turkey
[3] Hacettepe Univ, Inst Canc, Bone Marrow Transplantat Unit, Ankara, Turkey
[4] Ares Pharmaceut, Immunooncol Program, St Paul, MN 55110 USA
[5] Ares Pharmaceut, COVID 19 Task Force, St Paul, MN 55110 USA
来源：
ONCOLOGIST | 2022年 / 27卷 / 11期
关键词：
COVID-19; VACCINATION;
D O I：
10.1093/oncolo/oyac173
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E917 / E918
页数：2
相关论文
共 50 条
  • [1] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
    Malard, Florent
    Gaugler, Beatrice
    Gozlan, Joel
    Bouquet, Lucie
    Fofana, Djeneba
    Siblany, Lama
    Eshagh, Deborah
    Adotevi, Olivier
    Laheurte, Caroline
    Ricard, Laure
    Dulery, Remy
    Stocker, Nicolas
    van de Wyngaert, Zoe
    Genthon, Alexis
    Banet, Anne
    Memoli, Mara
    Ikhlef, Souhila
    Sestilli, Simona
    Vekhof, Anne
    Brissot, Eolia
    Marjanovic, Zora
    Chantran, Yannick
    Cuervo, Nancy
    Ballot, Eric
    Morand-Joubert, Laurence
    Mohty, Mohamad
    BLOOD CANCER JOURNAL, 2021, 11 (08)
  • [2] Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
    Florent Malard
    Béatrice Gaugler
    Joel Gozlan
    Lucie Bouquet
    Djeneba Fofana
    Lama Siblany
    Deborah Eshagh
    Olivier Adotevi
    Caroline Laheurte
    Laure Ricard
    Rémy Dulery
    Nicolas Stocker
    Zoe van de Wyngaert
    Alexis Genthon
    Anne Banet
    Mara Memoli
    Souhila Ikhlef
    Simona Sestilli
    Anne Vekhof
    Eolia Brissot
    Zora Marjanovic
    Yannick Chantran
    Nancy Cuervo
    Eric Ballot
    Laurence Morand-Joubert
    Mohamad Mohty
    Blood Cancer Journal, 11
  • [3] SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
    Haggenburg, Sabine
    Hofsink, Quincy
    Rutten, Caroline E.
    Nijhof, Inger S.
    Hazenberg, Mette D.
    Goorhuis, Abraham
    SEMINARS IN HEMATOLOGY, 2022, 59 (04) : 192 - 197
  • [4] SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
    Ni, Bin
    Yanis, Ahmad
    Dee, Kevin
    Chappell, James D.
    Dulek, Daniel E.
    Kassim, Adetola A.
    Kitko, Carrie L.
    Thomas, Lora D.
    Halasa, Natasha
    BLOOD REVIEWS, 2022, 56
  • [5] Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
    Greenberger, Lee M.
    Saltzman, Larry A.
    Senefeld, Jonathon W.
    Johnson, Patrick W.
    DeGennaro, Louis J.
    Nichols, Gwen L.
    CANCER CELL, 2021, 39 (08) : 1031 - 1033
  • [6] Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
    Jimenez, Moraima
    Roldan, Elisa
    Fernandez-Naval, Candela
    Villacampa, Guillermo
    Martinez-Gallo, Monica
    Medina-Gil, Daniel
    Peralta-Garzon, Soraya
    Pujadas, Gemma
    Hernandez, Cristina
    Pages, Carlota
    Gironella, Mercedes
    Fox, Laura
    Orti, Guillermo
    Barba, Pere
    Pumarola, Tomas
    Cabirta, Alba
    Catala, Eva
    Valentin, Mercedes
    Marin-Niebla, Ana
    Orfao, Alberto
    Gonzalez, Marcos
    Campins, Magda
    Ruiz-Camps, Isabel
    Valcarcel, David
    Bosch, Francesc
    Hernandez, Manuel
    Crespo, Marta
    Esperalba, Juliana
    Abrisqueta, Pau
    BLOOD ADVANCES, 2022, 6 (03) : 774 - 784
  • [7] Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
    Sriwijitalai, Won
    Wiwanitkit, Viroj
    ONCOLOGIST, 2022, 27 (11): : E916 - E916
  • [8] Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2
    Wang, Jun
    Shao, Liang
    Liang, Jing
    Wu, Qingming
    Zhu, Baoli
    Deng, Qiwen
    Liu, Zelin
    Liu, Liqiong
    Wang, Danyu
    Yu, Zhijian
    Tan, Xiaohua
    Wang, Fuxiang
    Meng, Jingye
    Xu, Xiaojun
    Xia, Zhongjun
    Li, Zhiming
    Wang, Hua
    Wang, Liang
    Wu, Wei
    Xie, Qi
    Huang, Xiaoxing
    Sun, Zhiqiang
    Zhang, Yu
    Zhou, Hao
    Zhou, Hui
    Yang, Wenyan
    Ren, Hua
    Liu, Zhe
    Qiao, Mingqiang
    Tang, Feifei
    Qi, Xiaofei
    Wu, Huijing
    Deng, Lijuan
    Gao, Li
    Zhang, Hongyan
    Chen, Peng
    Zhang, Hongyu
    Zhang, Xinyou
    Zhou, Jihao
    Tu, Chuanqing
    Guan, Ling
    Yin, Qian
    Shu, Rong
    Chen, Feng
    He, Mingxin
    Wang, Qiang
    Guo, Zhi
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (06) : 1495 - 1500
  • [9] Impaired serological response to SARS-CoV-2 mRNA vaccination in patients with hematologic malignancies
    Greenberger, Lee M.
    Saltzman, Larry A.
    Senefeld, Jonathon W.
    Johnson, Patrick W.
    DeGennaro, Louis J.
    Nichols, Gwen L.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [10] Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience
    Galvez, Carlos
    Nizamuddin, Imran
    Tuchman, Emily
    Doukas, Peter
    Reddy, Neha
    Altman, Jessica K.
    Winter, Jane N.
    Gordon, Leo I.
    Barth, Dylan
    Hodgins, Nicole
    Pro, Barbara
    Ma, Shuo
    Dinner, Shira
    Frankfurt, Olga
    Mehta, Jayesh
    Singhal, Seema
    Adekola, Kehinde
    Moreira, Jonathan
    Tanna, Sajal D.
    Wehbe, Firas
    Karmali, Reem
    BLOOD, 2020, 136
12345